Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 321

1.

Impaired SIRT1 activity leads to diminution in glomerular endowment without accelerating age-associated GFR decline.

Bellin AR, Zhang Y, Thai K, Rosenblum ND, Cullen-McEwen LA, Bertram JF, Gilbert RE.

Physiol Rep. 2019 May;7(9):e14044. doi: 10.14814/phy2.14044.

2.

Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: A meta-analysis of cardiovascular outcome trials.

Gilbert RE, Thorpe KE.

Diabetes Obes Metab. 2019 May 3. doi: 10.1111/dom.13754. [Epub ahead of print]

PMID:
31050116
3.

Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction.

Connelly KA, Zhang Y, Visram A, Advani A, Batchu SN, Desjardins JF, Thai K, Gilbert RE.

JACC Basic Transl Sci. 2019 Feb 25;4(1):27-37. doi: 10.1016/j.jacbts.2018.11.010. eCollection 2019 Feb.

4.

Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes: A systematic review and meta-analysis.

Fan H, Li L, Wijlaars L, Gilbert RE.

PLoS One. 2019 Feb 19;14(2):e0212212. doi: 10.1371/journal.pone.0212212. eCollection 2019.

5.

Reduction in the incidence of myocardial infarction with sodium-glucose linked cotransporter-2 inhibitors: evident and plausible.

Gilbert RE, Connelly KA.

Cardiovasc Diabetol. 2019 Jan 11;18(1):6. doi: 10.1186/s12933-019-0812-6. No abstract available.

6.

Reversing CXCL10 Deficiency Ameliorates Kidney Disease in Diabetic Mice.

Zhang Y, Thai K, Kepecs DM, Winer D, Gilbert RE.

Am J Pathol. 2018 Dec;188(12):2763-2773. doi: 10.1016/j.ajpath.2018.08.017. Epub 2018 Sep 29.

PMID:
30273603
7.

SIRT1 activation attenuates α cell hyperplasia, hyperglucagonaemia and hyperglycaemia in STZ-diabetic mice.

Zhang Y, Thai K, Jin T, Woo M, Gilbert RE.

Sci Rep. 2018 Sep 18;8(1):13972. doi: 10.1038/s41598-018-32351-z.

8.

Dual inhibition of sodium-glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction.

Connelly KA, Zhang Y, Desjardins JF, Thai K, Gilbert RE.

Cardiovasc Diabetol. 2018 Jul 7;17(1):99. doi: 10.1186/s12933-018-0741-9.

9.

Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.

Bugyei-Twum A, Ford C, Civitarese R, Seegobin J, Advani SL, Desjardins JF, Kabir G, Zhang Y, Mitchell M, Switzer J, Thai K, Shen V, Abadeh A, Singh KK, Billia F, Advani A, Gilbert RE, Connelly KA.

Cardiovasc Res. 2018 Oct 1;114(12):1629-1641. doi: 10.1093/cvr/cvy131.

PMID:
29800064
10.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.

PMID:
29731013
11.

Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study.

Gilbert RE, Kozak MC, Dobish RB, Bourrier VC, Koke PM, Kukreti V, Logan HA, Easty AC, Trbovich PL.

J Oncol Pract. 2018 May;14(5):e295-e303. doi: 10.1200/JOP.17.00007. Epub 2018 Apr 20.

12.

Chronic Kidney Disease in Diabetes.

Diabetes Canada Clinical Practice Guidelines Expert Committee, McFarlane P, Cherney D, Gilbert RE, Senior P.

Can J Diabetes. 2018 Apr;42 Suppl 1:S201-S209. doi: 10.1016/j.jcjd.2017.11.004. No abstract available.

PMID:
29650098
13.

Treatment of Diabetes in People With Heart Failure.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Connelly KA, Gilbert RE, Liu P.

Can J Diabetes. 2018 Apr;42 Suppl 1:S196-S200. doi: 10.1016/j.jcjd.2017.10.026. No abstract available.

PMID:
29650096
14.

Treatment of Hypertension.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Tobe SW, Gilbert RE, Jones C, Leiter LA, Prebtani APH, Woo V.

Can J Diabetes. 2018 Apr;42 Suppl 1:S186-S189. doi: 10.1016/j.jcjd.2017.10.011. No abstract available.

PMID:
29650094
15.

Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions.

Fleming JN, Taber DJ, Pilch NA, Mardis CR, Gilbert RE, Wilson LZ, Patel N, Ball S, Mauldin P, Baliga PK.

J Am Coll Surg. 2018 Apr;226(4):651-659. doi: 10.1016/j.jamcollsurg.2017.12.025. Epub 2018 Jan 5.

PMID:
29309943
16.

Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention).

Gerstein HC, Jung H, Rydén L, Diaz R, Gilbert RE, Yusuf S; ORIGIN Investigators.

Circulation. 2018 Jan 2;137(1):88-90. doi: 10.1161/CIRCULATIONAHA.117.030924. No abstract available.

PMID:
29279340
17.

The Twenty-Fifth Amendment and the establishment of medical impairment panels: are the two safely compatible?

Gilbert RE.

Fordham Law Rev. 2017 Dec;86(3):1111-35. No abstract available.

PMID:
29232076
18.

A guide to evaluating linkage quality for the analysis of linked data.

Harron KL, Doidge JC, Knight HE, Gilbert RE, Goldstein H, Cromwell DA, van der Meulen JH.

Int J Epidemiol. 2017 Oct 1;46(5):1699-1710. doi: 10.1093/ije/dyx177.

19.

Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial.

Ridyard CH, Plumpton CO, Gilbert RE, Hughes DA.

Front Pharmacol. 2017 Sep 19;8:644. doi: 10.3389/fphar.2017.00644. eCollection 2017.

20.

Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.

Papademetriou V, Nylen ES, Doumas M, Probstfield J, Mann JFE, Gilbert RE, Gerstein HC.

Am J Med. 2017 Dec;130(12):1465.e27-1465.e39. doi: 10.1016/j.amjmed.2017.05.047. Epub 2017 Aug 31.

PMID:
28842165
21.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NRC, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Kline G, Leiter LA, Jones C, Côté AM, Woo V, Kaczorowski J, Trudeau L, Tsuyuki RT, Hiremath S, Drouin D, Lavoie KL, Hamet P, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; Hypertension Canada.

Can J Cardiol. 2017 May;33(5):557-576. doi: 10.1016/j.cjca.2017.03.005. Epub 2017 Mar 10. Erratum in: Can J Cardiol. 2017 Dec;33(12 ):1733-1734.

PMID:
28449828
22.

Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease.

Gilbert RE.

Diabetes. 2017 Apr;66(4):791-800. doi: 10.2337/db16-0796. Review.

23.

Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials.

Gilbert RE, Mende C, Vijapurkar U, Sha S, Davies MJ, Desai M.

Diabetes Ther. 2017 Apr;8(2):451-458. doi: 10.1007/s13300-017-0232-0. Epub 2017 Feb 14.

24.

Finerenone in diabetic kidney disease - So far, so good.

Gilbert RE.

J Diabetes Complications. 2017 Apr;31(4):651-652. doi: 10.1016/j.jdiacomp.2016.12.012. Epub 2017 Jan 20. No abstract available.

PMID:
28153675
25.

Sirtuin 1 Activation Reduces Transforming Growth Factor-β1-Induced Fibrogenesis and Affords Organ Protection in a Model of Progressive, Experimental Kidney and Associated Cardiac Disease.

Zhang Y, Connelly KA, Thai K, Wu X, Kapus A, Kepecs D, Gilbert RE.

Am J Pathol. 2017 Jan;187(1):80-90. doi: 10.1016/j.ajpath.2016.09.016.

PMID:
27993241
26.

Antibiotic-impregnated catheters for prevention of bloodstream infection - Authors' reply.

Gilbert RE, Mok Q, Millar M, Blundell M.

Lancet. 2016 Nov 5;388(10057):2235-2236. doi: 10.1016/S0140-6736(16)31716-0. No abstract available.

PMID:
27825501
27.

SGLT2 inhibitors: β blockers for the kidney?

Gilbert RE.

Lancet Diabetes Endocrinol. 2016 Oct;4(10):814. doi: 10.1016/S2213-8587(16)30237-6. No abstract available.

PMID:
27663956
28.

Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD.

Kepecs DM, Yuen DA, Zhang Y, Thai K, Connelly KA, Gilbert RE.

J Renin Angiotensin Aldosterone Syst. 2016 Sep 15;17(3). pii: 1470320316668434. doi: 10.1177/1470320316668434. Print 2016 Jul.

29.

The Human Factor: Designing Safety Into Oncology Practice.

Gilbert RE.

J Oncol Pract. 2016 Oct;12(10):884-887. No abstract available.

PMID:
27328796
30.

Antibiotics versus no treatment for toxoplasma retinochoroiditis.

Pradhan E, Bhandari S, Gilbert RE, Stanford M.

Cochrane Database Syst Rev. 2016 May 20;(5):CD002218. doi: 10.1002/14651858.CD002218.pub2. Review.

PMID:
27198629
31.

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Harris KC, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; CHEP Guidelines Task Force.

Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.

PMID:
27118291
32.

Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies.

Gilbert RE, Weir MR, Fioretto P, Law G, Desai M, Kline I, Shaw W, Meininger G.

Can J Diabetes. 2016 Jun;40(3):247-57. doi: 10.1016/j.jcjd.2015.11.005. Epub 2016 Mar 24.

33.

Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.

Gilbert RE, Mok Q, Dwan K, Harron K, Moitt T, Millar M, Ramnarayan P, Tibby SM, Hughes D, Gamble C; CATCH trial investigators.

Lancet. 2016 Apr 23;387(10029):1732-42. doi: 10.1016/S0140-6736(16)00340-8. Epub 2016 Mar 4.

PMID:
26946925
34.

CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.

Harron K, Mok Q, Dwan K, Ridyard CH, Moitt T, Millar M, Ramnarayan P, Tibby SM, Muller-Pebody B, Hughes DA, Gamble C, Gilbert RE.

Health Technol Assess. 2016 Mar;20(18):vii-xxviii, 1-219. doi: 10.3310/hta20180.

35.

Recombinant N-Terminal Slit2 Inhibits TGF-β-Induced Fibroblast Activation and Renal Fibrosis.

Yuen DA, Huang YW, Liu GY, Patel S, Fang F, Zhou J, Thai K, Sidiqi A, Szeto SG, Chan L, Lu M, He X, John R, Gilbert RE, Scholey JW, Robinson LA.

J Am Soc Nephrol. 2016 Sep;27(9):2609-15. doi: 10.1681/ASN.2015040356. Epub 2016 Feb 11.

36.

Henry Krum, Pioneering Heart Failure Researcher.

Gilbert RE, Ruschitzka F.

Eur J Heart Fail. 2016 Feb;18(2):125-6. doi: 10.1002/ejhf.498. No abstract available.

37.

Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes.

Duarte DA, Papadimitriou A, Gilbert RE, Thai K, Zhang Y, Rosales MA, Lopes de Faria JB, Lopes de Faria JM.

PLoS One. 2016 Feb 2;11(2):e0147978. doi: 10.1371/journal.pone.0147978. eCollection 2016.

38.

Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease.

Zhang Y, Thai K, Kepecs DM, Gilbert RE.

PLoS One. 2016 Jan 7;11(1):e0144640. doi: 10.1371/journal.pone.0144640. eCollection 2016.

39.

Understanding EMPA-REG OUTCOME.

Gilbert RE, Connelly KA.

Lancet Diabetes Endocrinol. 2015 Dec;3(12):930-1. doi: 10.1016/S2213-8587(15)00427-1. No abstract available.

PMID:
26590681
40.

Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trial.

Yuen DA, Kepecs DM, Zhang Y, Advani S, Thai K, Connelly KA, Gilbert RE.

Can J Kidney Health Dis. 2015 Nov 14;2:44. doi: 10.1186/s40697-015-0082-5. eCollection 2015.

41.

ReCAP: Comparison of Independent Error Checks for Oral Versus Intravenous Chemotherapy.

Griffin MC, Gilbert RE, Broadfield LH, Easty AE, Trbovich PL, Griffin MC, Gilbert RE, Broadfield LH, Easty AE, Trbovich PL.

J Oncol Pract. 2016 Feb;12(2):168-9; e180-7. doi: 10.1200/JOP.2015.005892. Epub 2015 Sep 29.

PMID:
26420888
42.

Heart failure: fatal, forgotten, and frequent in type 1 diabetes too.

Gilbert RE.

Lancet Diabetes Endocrinol. 2015 Nov;3(11):832-4. doi: 10.1016/S2213-8587(15)00329-0. Epub 2015 Sep 18. No abstract available.

PMID:
26388414
43.

Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.

Gilbert RE, Krum H.

Lancet. 2015 May 23;385(9982):2107-17. doi: 10.1016/S0140-6736(14)61402-1. Review.

PMID:
26009231
44.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Ramesh Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Brian Penner S, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Stone JA, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Fournier A, Lewanczuk R, Dresser GK, Sharma M, Reid D, Benoit G, Feber J, Harris KC, Poirier L, Padwal RS.

Can J Cardiol. 2015 May;31(5):549-68. doi: 10.1016/j.cjca.2015.02.016. Review.

PMID:
25936483
45.

The politics of presidential illness. Ronald Reagan and the Iran-Contra Scandal.

Gilbert RE.

Politics Life Sci. 2014 Fall;33(2):58-76. doi: 10.2990/33_2_58.

PMID:
25901884
46.

Introduction. Presidential disability and presidential succession.

Gilbert RE, Bucy EP.

Politics Life Sci. 2014 Fall;33(2):2-9. doi: 10.2990/33_2_2.

PMID:
25901881
47.

Are SGLT2 inhibitors reasonable antihypertensive drugs and renoprotective?

Lovshin JA, Gilbert RE.

Curr Hypertens Rep. 2015 Jun;17(6):551. doi: 10.1007/s11906-015-0551-3. Review.

PMID:
25893475
48.

Application of Modular Therapy for Renoprotection in Experimental Chronic Kidney Disease.

Kepecs DM, Zhang Y, Thai K, Advani SL, Yuen DA, Connelly KA, Kosanam H, Diamandis E, Sefton MV, Gilbert RE.

Tissue Eng Part A. 2015 Jul;21(13-14):1963-72. doi: 10.1089/ten.TEA.2014.0017. Epub 2015 Mar 20.

PMID:
25661544
49.

Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α.

Connelly KA, Advani A, Zhang Y, Advani SL, Kabir G, Abadeh A, Desjardins JF, Mitchell M, Thai K, Gilbert RE.

J Diabetes. 2016 Jan;8(1):63-75. doi: 10.1111/1753-0407.12258. Epub 2015 Mar 4.

PMID:
25565455
50.

SIRT1 activation ameliorates hyperglycaemia by inducing a torpor-like state in an obese mouse model of type 2 diabetes.

Gilbert RE, Thai K, Advani SL, Cummins CL, Kepecs DM, Schroer SA, Woo M, Zhang Y.

Diabetologia. 2015 Apr;58(4):819-27. doi: 10.1007/s00125-014-3485-4. Epub 2015 Jan 7.

PMID:
25563725

Supplemental Content

Loading ...
Support Center